(Q33494133)
Statements
Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia (English)
C D Buckner
1 reference
M C Benyunes
C Massumoto
A York
C M Higuchi
J A Thompson
F B Petersen